P16 immunoreactivity is an independent predictor of tumor progression in minimally invasive urothelial bladder carcinoma (Q81537128)
Jump to navigation
Jump to search
scientific article published on 08 January 2005
Language | Label | Description | Also known as |
---|---|---|---|
English | P16 immunoreactivity is an independent predictor of tumor progression in minimally invasive urothelial bladder carcinoma |
scientific article published on 08 January 2005 |
Statements
P16 immunoreactivity is an independent predictor of tumor progression in minimally invasive urothelial bladder carcinoma (English)
Stefan Krüger
Anne Mahnken
Ingo Kausch